Join the SOSV DEEP TECH SUMMIT, NOV 4-6. (FREE AND VIRTUAL ) Register Today →

FREZENT Biological Solutions

Preventing cancer recurrence by targeting dormant cells

Company details

Frezent develops first-in-class antibody and antibody-drug conjugate therapies to prevent cancer recurrence by targeting dormant, non-dividing cancer cells. Its approach blocks dormant cell reactivation through the tumor microenvironment’s nutrient and growth-factor dependencies. Programs are designed for use alongside standard of care in head and neck cancer and other malignancies, with potential future maintenance therapy applications.

There are more than 32 million cancer survivors worldwide and every second person will hear that the cancer is back.

FREZENT Biological Solutions Quote Image
Natasha Shtraizent, PhD, co-founder and CEO
“Chemotherapy is an effective cancer treatment. However, a few cancer cells can stay behind after the initial treatment, lingering like a ticking time bomb. We want to diffuse this time bomb, and give cancer survivors the confidence that the cancer won’t return.”

Team

Lina Freage

Co-Founder & Chief Scientific Officer

Natasha Shtraizent

Co-Founder & CEO

Get In Touch with FREZENT Biological Solutions

Please tell us a little bit about yourself and why you'd like to get connected. FREZENT Biological Solutions + SOSV will follow up with you via email.

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.